Technology tamfitronics
A strategic move by lawyers acting for Doudna and Charpentier is the latest twist in the battleground for CRISPRCas9 technology.
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
24,99 /30days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
214,86 per year
only 17,91 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Harrison, C. CRISPR Nobelists surrender their own European patents. Nat Biotechnol (2024). https://doi.org/10.1038/s41587-024-02472-0
Download citation
Published:
DOI: https://doi.org/10.1038/s41587-024-02472-0
